The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Landscape of targeted therapies for advanced urothelial carcinoma”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Antonio Lopez‐Beltran, Ana Blanca, Michelle R. Downes, Alessia Cimadamore, Rodolfo Montironi, Liang Cheng. Molecular pathology of bladder cancer, Histopathology. 2026; 88: 65. https://doi.org/10.1111/his.15555 |
|
2 |
2026 |
Li-Ching Wu, Zhi-Hao Chen, Ti-Chun Chan, Yow-Ling Shiue, Chien-Feng Li. Downregulation of Gastrokine 1 expression facilitates tumor progression in urothelial carcinomas, Oncologie. 2026; https://doi.org/10.1515/oncologie-2025-0548 |
|
3 |
2026 |
Ben He, He Xu, Hui Zhuo. Prognostic value of preoperative pan-immune inflammation in non-muscle invasive bladder urothelial carcinoma, Asian Journal of Surgery. 2026; https://doi.org/10.1016/j.asjsur.2026.02.107 |
|
4 |
2025 |
Thomas B. Powles, Enrique Grande, Nimira Alimohamed, Niara Oliveira, Srikala S. Sridhar, Alexandra Drakaki, Ravindran Kanesvaran, Yohann Loriot, Andrea Necchi, Sonia Franco, Dingfeng Jiang, Kristel Apolinario, Wei Zhang, Matthew D. Galsky. SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma, Future Oncology. 2025; 21: 2705. https://doi.org/10.1080/14796694.2025.2535280 |
|
5 |
2026 |
Dimitar Ugrinovski, Skender Saidi, Viktor Stankov, Martina Ambardjieva, Slavica Josifovska, Anne-Katrin Koehler, Joerg Gabert, Sasho Panov. Pan-Cancer Targeted Sequencing Reveals Genomic Heterogeneity and Prognostic Subgroups in Urothelial Bladder Cancer, Cancers. 2026; 18: 1026. https://doi.org/10.3390/cancers18061026 |